The disease affects as many as 80 million in the U.S. alone. Now Apnimed, the $400 million company behind the first ever pill to treat it, is preparing to file for FDA approval. In November 2016, ...
The American Medical Association reports that about 30 million people in the US live with sleep apnea, but only one-fifth of these cases are clinically diagnosed. That means that many people are ...